Moreover, we speculated that a combination of three markers of Se status, namely total-Se, activity of the extracellular selenoprotein glutathione peroxidase-3 (GPx3) and concentration of SELENOP provides more accurate prognostic information than a single marker alone, as shown before in breast cancer [29]. The gene discussed is GPX3; the disease is breast cancer.